NABL Certified Labs

Book Total Iron Binding Capacity Test

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹367

Book Now
Free Home Collection Reports In 24 - 48 Hours

Quick Total Iron Binding Capacity Test Overview

Also Known As Total Iron Binding Capacity Test, Transferrin Capacity Test, Iron Studies
Sample Type Blood (serum)
Fasting Required Yes, 8 to 12 hours; morning collection strongly recommended
Report Delivery Within 24 hours
Age Group All ages
Gender All
Test Type Colorimetric or immunoturbidimetric assay
Units mcg/dL (micrograms per decilitre)
1

The TIBC test, or Total Iron Binding Capacity test, is a blood test that measures the maximum amount of iron that transferrin, the body's primary iron transport protein, is capable of carrying in the bloodstream. Transferrin binds iron in the blood and delivers it to the bone marrow for red blood cell production and to other tissues that require iron for essential metabolic functions. When iron stores are depleted, the liver produces more transferrin in an attempt to capture and transport whatever iron is available, causing TIBC to rise. Conversely, when iron stores are excessive or transferrin production is reduced due to liver disease or inflammation, TIBC falls. TIBC is most clinically valuable not as a standalone test but as a critical component of the complete iron studies panel alongside serum iron, transferrin saturation, and ferritin. Together these four parameters provide a comprehensive and accurate picture of the body's iron status that no single test can deliver alone. In India, where iron deficiency is the most prevalent nutritional deficiency affecting hundreds of millions across all age groups, and where iron overload conditions including haemochromatosis are also increasingly recognised, TIBC is an essential diagnostic tool for accurately characterising iron disorders and distinguishing true iron deficiency from anaemia of chronic disease, a clinically important distinction that determines the appropriate treatment approach. The test involves a simple blood draw completed in under five minutes.
2

Doctors prescribe a TIBC test in the following situations: Confirming iron deficiency anaemia where an elevated TIBC alongside low serum iron and low ferritin provides the complete diagnostic picture of depleted iron stores driving the body to upregulate transferrin production in an attempt to maximise iron capture from the circulation. Distinguishing iron deficiency anaemia from anaemia of chronic disease, where TIBC is elevated in true iron deficiency but normal or low in anaemia of chronic disease where inflammatory cytokines suppress transferrin production despite low serum iron, a distinction that fundamentally changes the treatment approach. Calculating transferrin saturation, which is serum iron divided by TIBC multiplied by 100, providing the percentage of transferrin binding sites currently occupied by iron. A low transferrin saturation below 20% confirms iron deficiency while a high saturation above 45% raises concern for iron overload. Evaluating suspected hereditary haemochromatosis where a markedly elevated transferrin saturation calculated from TIBC alongside elevated serum iron and ferritin confirms pathological iron overload in organs including the liver, heart, and pancreas requiring urgent specialist evaluation. Assessing iron status in pregnant women where iron requirements increase substantially and accurate iron status characterisation through the full iron panel guides supplementation decisions and prevents both undertreatment and unnecessary iron loading. Monitoring iron replacement therapy in patients on oral or intravenous iron supplementation where normalisation of TIBC alongside rising ferritin and serum iron confirms that iron stores are being adequately replenished. Evaluating liver disease and nutritional status where a low TIBC reflects reduced hepatic transferrin synthesis seen in cirrhosis, severe malnutrition, and nephrotic syndrome where protein loss reduces transferrin levels independently of iron status.
3

The TIBC test measures the total iron-binding capacity of transferrin in the blood, reported in micrograms per decilitre (mcg/dL). Normal TIBC Range in India The standard reference ranges used across most Indian diagnostic laboratories are as follows. For adults, a normal TIBC level is between 250 and 370 mcg/dL. Values may vary slightly between laboratories depending on the analytical method used. Interpreting TIBC Results An elevated TIBC above 370 mcg/dL alongside low serum iron and low ferritin is the classic and confirmatory pattern of iron deficiency, reflecting the body's compensatory upregulation of transferrin production to maximise iron transport in the setting of depleted stores. A normal or low TIBC between 150 and 250 mcg/dL alongside low serum iron but normal or elevated ferritin is the characteristic pattern of anaemia of chronic disease, where inflammatory suppression of transferrin synthesis and iron sequestration within macrophages rather than true iron depletion is the underlying mechanism. A low TIBC below 250 mcg/dL alongside elevated serum iron and elevated ferritin with a transferrin saturation above 45% raises concern for iron overload conditions including hereditary haemochromatosis, repeated blood transfusions, or excessive iron supplementation, all requiring further specialist evaluation.
4

Fasting for 8 to 12 hours before the test is recommended and the sample should ideally be collected in the morning, as both serum iron and transferrin saturation calculated from TIBC show significant diurnal variation with highest values in the morning. Our team confirms preparation requirements at the time of booking. Do not take iron supplements for at least 24 to 48 hours before the test as recently ingested iron can transiently raise serum iron and alter transferrin saturation, masking true iron deficiency or producing a misleadingly abnormal result. Inform the phlebotomist about all medications you are currently taking, particularly oral contraceptives which raise TIBC, and corticosteroids and testosterone which lower TIBC, as these must be disclosed for accurate interpretation of results. Avoid recent blood transfusions before the test as transfused blood alters both serum iron and the iron binding dynamics of transferrin and will not accurately reflect your body's true iron status. Stay normally hydrated before sample collection.
5

If you are booking through the SecondMedic platform the TIBC test price starts at approximately Rs. 367. The exact price will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside TIBC, SecondMedic health packages include TIBC as part of a broader iron studies or anaemia evaluation panel at a significantly lower combined price.
6

SecondMedic provides home sample collection for TIBC test across all major areas in India. You do not need to visit a lab or collection centre. A certified and trained phlebotomist comes to your home or workplace at your chosen time, collects the sample using sterile single-use equipment, and ensures it is transported to the NABL-accredited lab within the required time window for accurate processing. Please note that SecondMedic provides free home sample collection on all tests priced above Rs. 300. Our team will check your pincode and confirm if your address falls under our free sample collection eligibility criteria, which depends upon the lab location and phlebotomist availability. Home collection is available between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Enter your pincode on the booking page or call our helpline to confirm availability at your address.

Our Presence In India

People Also Ask

When iron stores are depleted, the liver upregulates transferrin production as a compensatory mechanism to maximise the capture and transport of the limited iron available in the circulation. More transferrin means more available binding sites for iron, which is what TIBC measures. A rising TIBC is therefore a direct reflection of the body actively trying to compensate for iron depletion.

Transferrin saturation is calculated by dividing serum iron by TIBC and multiplying by 100 to express the result as a percentage. It indicates what proportion of available transferrin binding sites are currently occupied by iron. A saturation below 20% confirms iron deficiency while a saturation above 45% raises concern for iron overload, making it one of the most clinically useful values derived from the iron studies panel.

In iron deficiency anaemia, the body is genuinely depleted of iron, so TIBC rises as the liver produces more transferrin to capture available iron. In anaemia of chronic disease, inflammatory cytokines such as hepcidin suppress transferrin synthesis and sequester iron within macrophages. As a result, TIBC is normal or low despite low serum iron, providing the critical differentiating pattern that guides the clinician toward treating the underlying inflammatory disease rather than supplementing iron.

Oestrogen, including that in oral contraceptive pills and hormone replacement therapy, stimulates hepatic transferrin synthesis, raising TIBC above the normal range even in the absence of iron deficiency. Women taking oestrogen-containing medications may therefore show elevated TIBC that does not reflect iron status. Disclosing contraceptive use before testing is essential for correct interpretation.

Transferrin is synthesised exclusively in the liver. In cirrhosis, hepatitis, and other conditions causing significant hepatocellular damage, the liver loses its capacity to produce normal amounts of transferrin, causing TIBC to fall. A low TIBC in a patient with known liver disease does not indicate iron overload and must be interpreted in the clinical context of liver function tests and overall protein synthetic capacity.

Hereditary haemochromatosis is characterised by a low or low-normal TIBC alongside elevated serum iron and a markedly elevated transferrin saturation, typically above 45% and often exceeding 60 to 70%. The elevated ferritin reflects iron accumulation in organs. This pattern on iron studies is the trigger for HFE gene mutation testing and specialist haematological or hepatological evaluation.

Yes. In nephrotic syndrome, large amounts of protein including transferrin are lost through the damaged kidney filtration membrane. This urinary protein loss reduces circulating transferrin levels and lowers TIBC, independent of iron status. A low TIBC in a patient with nephrotic syndrome therefore reflects protein depletion rather than iron overload and must be interpreted accordingly alongside serum albumin and 24-hour urine protein measurements.

As iron stores are replenished through oral or intravenous supplementation, rising ferritin signals to the liver that iron availability is improving, gradually reducing the stimulus for excess transferrin production. TIBC progressively falls back toward the normal range over weeks to months of adequate supplementation. A normalising TIBC alongside rising serum iron and ferritin provides objective confirmation that iron stores are being successfully restored.

Yes. Patients requiring chronic transfusions, such as those with thalassaemia major or sickle cell disease, are at risk of cumulative transfusional iron overload. In this setting, a low TIBC alongside progressively rising ferritin and elevated transferrin saturation signals iron accumulation, prompting evaluation for iron chelation therapy to prevent organ damage from iron deposition in the liver, heart, and endocrine glands.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
World Health Organization: Serum Transferrin Receptor Levels for the Assessment of Iron Status, WHO Vitamin and Mineral Nutrition Information System, 2014 — www.who.int
2
Camaschella C: Iron Deficiency Anaemia, New England Journal of Medicine, 201 — www.nejm.org
3
European Association for the Study of the Liver: EASL Clinical Practice Guidelines on Haemochromatosis, Journal of Hepatology, 2022 — www.journal-of-hepatology.eu
4
Weiss G and Goodnough LT: Anaemia of Chronic Disease, New England Journal of Medicine, 2005 — www.nejm.org
5
Indian Council of Medical Research: Micronutrient Profile of Indian Population, National Nutrition Monitoring Bureau, 2012 — www.nnmbindia.org

Download Our App & Get Consultation from anywhere.

App Download